Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01385852
Other study ID # 10-005
Secondary ID
Status Completed
Phase Phase 4
First received June 28, 2011
Last updated June 5, 2012
Start date May 2010
Est. completion date August 2011

Study information

Verified date June 2012
Source Iladevi Cataract and IOL Research Center
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Understanding and modulating fluid parameters is an important, but often overlooked aspect of phacoemulsification. In a previous study we compared the impact of using high fluid parameters versus low fluidic parameters on real-time IOP measured during phacoemulsification. The investigators found that using high parameters resulted in a higher absolute rise in IOP as well as higher fluctuations in the IOP when compared to low parameters. Clinically these higher fluctuations in IOP would translate in a higher chamber instability. Based on the results of this study, the investigators decided to take it further and study the impact of using high parameters (and thus, higher chamber instability) on macular edema and thickness following surgery, in an otherwise uncomplicated surgery.

Higher fluid parameters during phacoemulsification predisposes the eye to increased macular thickness


Description:

Several studies have shown the adverse impact of an increase in the IOP and IOP fluctuations that occur during anterior segment intervention on the posterior segment structures. In human volunteers with each incremental increase in IOP the systolic and diastolic flow velocities in the short posterior ciliary arteries decreased linearly. This implies that the normal healthy eye is not able to autoregulate to maintain posterior ciliary artery blood flow velocities in response to acute large elevations in IOP. Vascular insufficiency due to abnormal autoregulation has been proposed as a major factor in the development of glaucoma. 1

It has been postulated that IOP elevation during the LASIK procedure causes mechanical stress which may induce tangential stress on the posterior segment.2, 3 Some studies have reported that the increase in IOP damages the retinal ganglion cells causing visual field defects. Also sudden increases in IOP, although well tolerated may induce changes in the peripheral retina.4,5,6

Several reports propose the occurrence of macular hole, lacquer cracks and choroidal neovascular membranes following the LASIK procedure. 3 It has been observed that the rapidly fluctuating pressure variations may be detrimental, particularly in susceptible persons with compromised ocular blood flow. Rapid IOP changes across a 30-mm Hg range would be predicted to influence posterior segment blood vessels.

In a previous study we compared the impact of using high fluid parameters versus low fluidic parameters on real-time IOP measured during phacoemulsification. We found that using high parameters resulted in a higher absolute rise in IOP as well as higher fluctuations in the IOP when compared to low parameters. Clinically these higher fluctuations in IOP would translate in a higher chamber instability.

We hypothesize that although transient, the increased IOP that occurs during phacoemulsification when using high parameters could cause mechanical stress on the eye. These higher fluid parameters during phacoemulsification can predispose the eye to increased macular thickness.

To the best of our knowledge there are no published data on impact of IOP changes and fluctuation that are induced during cataract surgery on the macula. To investigate this further, we decided to study the impact of using high parameters (and thus, higher chamber instability) on macular thickness following surgery, in an otherwise uncomplicated surgery.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date August 2011
Est. primary completion date February 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

1. Uncomplicated, Age-related cataract.

2. Nuclear sclerosis: upto grade 3

3. Age: 40-70 years

4. Axial length: 21.5 mm to 24.5 mm

Exclusion Criteria:

1. Diabetes mellitus

2. Co-existing ocular disease- uveitis, glaucoma, PEX

3. Pre-existing macular pathology (eg.ARMD)

4. Previously operated eyes

5. Under treatment with Topical or systemic steroids / NSAID's

6. Intraoperative complications- PCR, Descemet's detachment, uveal trauma

7. Post operative complications - severe inflammation (>grade 3), rise in IOP

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
microcoaxial phacoemulsification
conventional longitudinal ultrasound

Locations

Country Name City State
India Raghudeep Eye Clinic Ahmedabad Gujarat

Sponsors (1)

Lead Sponsor Collaborator
Iladevi Cataract and IOL Research Center

Country where clinical trial is conducted

India, 

References & Publications (7)

Bélair ML, Kim SJ, Thorne JE, Dunn JP, Kedhar SR, Brown DM, Jabs DA. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009 Jul;148(1):128-35.e2. doi: 10.101 — View Citation

Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond). 2008 Jan;22(1):8-12. Epub 2006 Jun 2. — View Citation

Cagini C, Fiore T, Iaccheri B, Piccinelli F, Ricci MA, Fruttini D. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Curr Eye Res. 2009 Dec;34(12):1036-4 — View Citation

Kim SJ, Belair ML, Bressler NM, Dunn JP, Thorne JE, Kedhar SR, Jabs DA. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina. 2008 Jun;28(6):870-6. doi: 10.1097/IAE.0b013e318169d04e. — View Citation

Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007 May;114(5):881-9. Epub 2007 Feb 1. — View Citation

Lee YC, Chung FL, Chen CC. Intraocular pressure and foveal thickness after phacoemulsification. Am J Ophthalmol. 2007 Aug;144(2):203-208. Epub 2007 May 30. — View Citation

Perente I, Utine CA, Ozturker C, Cakir M, Kaya V, Eren H, Kapran Z, Yilmaz OF. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007 Mar;32(3):241-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary cystoid macular edema (CME) A > or = 30% increase in baseline central foveal thickness measaured by anterior segment OCT will be defined as having CME. 3 months Yes
Secondary macular thickness macular thickness measured in 3 zones using the anterior segment OCT 1, 3 months Yes
Secondary central corneal thickness (CCT) CCT will be measured on the ultrasound pachymeter by a single experienced observer first post-operative day, Yes
Secondary endothelial cell loss Endothelial cell loss will be measured using a specular microscope in the central area by a single technician 6 months post-operative Yes
Secondary anterior chamber inflammation it will be assessed on the slit lamp examination by a single experienced observer using the Hogan's criteria 1 months Yes
Secondary CORRECTED DISTANCE VISUAL ACUITY (CDVA) visual acuity (VA) of 20/40 or worse was defined as "clinically significant" 3 months Yes
See also
  Status Clinical Trial Phase
Completed NCT01546402 - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema Phase 4
Completed NCT04940338 - PCME Prevention in Patients With NPDR Phase 4
Completed NCT05811182 - Vitreous Hyper Reflective Dots in Association With Pseudophakic Cystoid Macular Edema

External Links